← All trials
NCT05219604
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2022
- Primary completion
- Oct 4, 2022
- Completion date
- Oct 4, 2022
- First posted
- Feb 2, 2022
- Last posted
- Oct 6, 2022
- Enrollment
- 3
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dent Neuroscience Research CenterLead sponsor
- Dent Neurologic InstituteOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.